Dahu Aquaculture Co.,Ltd. completed the acquisition of 8% stake in Dongfang Huakang Medical Management Co., Ltd. from Kafu Health Technology Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan.
January 31, 2020
Share
Dahu Aquaculture Co.,Ltd. (SHSE:600257) agreed to acquire 8% stake in Dongfang Huakang Medical Management Co., Ltd. from Kafu Health Technology (Shanghai) Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan for CNY 50 million on January 16, 2020. Dahu Aquaculture Co.,Ltd will acquire 3.46%, 2.34%, 1.98% and 0.22% stake from Kafu Health Technology (Shanghai) Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan for CNY 21.6 million, CNY 14.59 million, CNY 12.39 million and CNY 1.4 million respectively. Post completion, Kafu Health Technology (Shanghai) Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan will hold 42.96%, 17.36%, 16.02% and 1.78% stake respectively. As of December 31, 2019, Dongfang Huakang Medical Management Co., Ltd. reported total assets of CNY 182.8 million, net assets of CNY 130.3 million. For the year 2019, Dongfang Huakang Medical Management Co., Ltd. reported operating revenue of CNY 87.7 million and net loss of CNY 26.6 million. The Board of Directors of Dahu Aquaculture Co.,Ltd. has approved the transaction and its shareholders approval is not required.
Dahu Aquaculture Co.,Ltd. (SHSE:600257) completed the acquisition of 8% stake in Dongfang Huakang Medical Management Co., Ltd. from Kafu Health Technology (Shanghai) Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan in January 2020.
DAHU AQUACULTURE CO., LTD. is a China-based company, principally engaged in the breeding and processing of aquatic products, as well as the manufacturing and distribution of wines and pharmaceuticals. The Company's main products are freshwater fish, including bighead carps, silver carps and soft-shelled turtle. The Company conducts its businesses mainly within domestic markets.
Dahu Aquaculture Co.,Ltd. completed the acquisition of 8% stake in Dongfang Huakang Medical Management Co., Ltd. from Kafu Health Technology Co., Ltd., Shanghai Lianchuang Junzhe Venture Capital Center (Limited Partnership), Shanghai Lianchuang Yongyi Phase II Equity Investment Fund Partnership (Limited Partnership) and Li Aichuan.
DAHU AQUACULTURE CO.,LTD. 
